annual D&A:
$7.37M+$3.81M(+106.82%)Summary
- As of today (July 1, 2025), KYMR annual depreciation & amortization is $7.37 million, with the most recent change of +$3.81 million (+106.82%) on December 31, 2024.
- During the last 3 years, KYMR annual D&A has risen by +$4.98 million (+207.59%).
- KYMR annual D&A is now at all-time high.
Performance
KYMR Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$2.05M+$61.00K(+3.07%)Summary
- As of today (July 1, 2025), KYMR quarterly depreciation & amortization is $2.05 million, with the most recent change of +$61.00 thousand (+3.07%) on March 31, 2025.
- Over the past year, KYMR quarterly D&A has increased by +$587.00 thousand (+40.18%).
- KYMR quarterly D&A is now at all-time high.
Performance
KYMR quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$7.96M+$587.00K(+7.96%)Summary
- As of today (July 1, 2025), KYMR TTM depreciation & amortization is $7.96 million, with the most recent change of +$587.00 thousand (+7.96%) on March 31, 2025.
- Over the past year, KYMR TTM D&A has increased by +$3.81 million (+91.95%).
- KYMR TTM D&A is now at all-time high.
Performance
KYMR TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
KYMR Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +106.8% | +40.2% | +92.0% |
| 3 y3 years | +207.6% | +198.1% | +206.3% |
| 5 y5 years | +793.7% | +429.2% | +925.8% |
KYMR Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +207.6% | at high | +190.5% | at high | +189.2% |
| 5 y | 5-year | at high | +793.7% | at high | +426.5% | at high | +925.8% |
| alltime | all time | at high | +3496.6% | at high | +429.2% | at high | +1956.8% |
KYMR Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $2.05M(+3.1%) | $7.96M(+8.0%) |
| Dec 2024 | $7.37M(+106.8%) | $1.99M(0.0%) | $7.37M(+17.5%) |
| Sep 2024 | - | $1.99M(+2.5%) | $6.28M(+21.1%) |
| Jun 2024 | - | $1.94M(+32.6%) | $5.18M(+25.0%) |
| Mar 2024 | - | $1.46M(+64.0%) | $4.15M(+16.3%) |
| Dec 2023 | $3.56M(+19.8%) | $891.00K(-0.4%) | $3.56M(+2.1%) |
| Sep 2023 | - | $895.00K(-0.6%) | $3.49M(+3.8%) |
| Jun 2023 | - | $900.00K(+2.4%) | $3.36M(+6.2%) |
| Mar 2023 | - | $879.00K(+7.5%) | $3.17M(+6.4%) |
| Dec 2022 | $2.98M | $818.00K(+6.6%) | $2.98M(+4.5%) |
| Sep 2022 | - | $767.00K(+8.8%) | $2.85M(+3.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $705.00K(+2.6%) | $2.75M(+5.9%) |
| Mar 2022 | - | $687.00K(-0.3%) | $2.60M(+8.4%) |
| Dec 2021 | $2.40M(+36.0%) | $689.00K(+2.7%) | $2.40M(+8.7%) |
| Sep 2021 | - | $671.00K(+21.6%) | $2.21M(+8.9%) |
| Jun 2021 | - | $552.00K(+13.8%) | $2.02M(+8.8%) |
| Mar 2021 | - | $485.00K(-2.4%) | $1.86M(+5.6%) |
| Dec 2020 | $1.76M(+113.7%) | $497.00K(+1.4%) | $1.76M(+39.3%) |
| Sep 2020 | - | $490.00K(+26.0%) | $1.27M(+63.1%) |
| Jun 2020 | - | $389.00K(+0.5%) | $776.00K(+100.5%) |
| Mar 2020 | - | $387.00K | $387.00K |
| Dec 2019 | $825.00K(+302.4%) | - | - |
| Dec 2018 | $205.00K | - | - |
FAQ
- What is Kymera Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Kymera Therapeutics?
- What is Kymera Therapeutics annual D&A year-on-year change?
- What is Kymera Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly D&A year-on-year change?
- What is Kymera Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Kymera Therapeutics?
- What is Kymera Therapeutics TTM D&A year-on-year change?
What is Kymera Therapeutics annual depreciation & amortization?
The current annual D&A of KYMR is $7.37M
What is the all time high annual D&A for Kymera Therapeutics?
Kymera Therapeutics all-time high annual depreciation & amortization is $7.37M
What is Kymera Therapeutics annual D&A year-on-year change?
Over the past year, KYMR annual depreciation & amortization has changed by +$3.81M (+106.82%)
What is Kymera Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of KYMR is $2.05M
What is the all time high quarterly D&A for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly depreciation & amortization is $2.05M
What is Kymera Therapeutics quarterly D&A year-on-year change?
Over the past year, KYMR quarterly depreciation & amortization has changed by +$587.00K (+40.18%)
What is Kymera Therapeutics TTM depreciation & amortization?
The current TTM D&A of KYMR is $7.96M
What is the all time high TTM D&A for Kymera Therapeutics?
Kymera Therapeutics all-time high TTM depreciation & amortization is $7.96M
What is Kymera Therapeutics TTM D&A year-on-year change?
Over the past year, KYMR TTM depreciation & amortization has changed by +$3.81M (+91.95%)